Platelet-Rich Plasma

Clinically Proven Platelet-Rich Plasma Treatments

cd29f1ac158b7f18c7305c0d01fc56d3b5fda090_s2_n1

Platelet-Rich Plasma Therapy

What Is It?

PRP has been used in dermatology, plastic surgery, aesthetic medicine, wound healing, sports medicine, and orthopaedics for many years.

The PRP system offered at DermNurse Medical Aesthetics involves extracting a small amount of the clients’ blood and spinning it down to create a platelet-rich plasma (A.K.A. Liquid Gold), which contains concentrated amounts of the clients’ own growth factors. When injected into the skin, these growth factors stimulate stem cells and fibroblasts.

PRP has been clinically proven to safely restore volume where volume has been lost (e.g., tear troughs), reverse hair loss, and improve skin density, appearance, and texture.
*It has been supported clinically as a safe alternative to dermal fillers.

Our process is backed by clinical research as most effective in producing the best PRP results. For example, we use a twice sterile wrapped double syringe and spin the blood to produce PRP with approximately 2.5 times the normal concentration and practically free from red and white blood cells, thereby producing the most clinically significant results. Unlike other systems, there are no stabilizers added to the PRP, so the product injected into your skin is 100% pure from your body and back to your body. Lastly, the safety and efficiency of this process/system have been approved by the Health Canada and FDA.

Ideally, 3 treatments spaced 4 weeks apart are required for optimal results. The results, once achieved, typically last 1-2 years. You will need a re-treatment after 1-2 years.
*Lifestyle factors can influence the longevity of results.

Typically, swelling is reported within the first 24 hours of treatment, lasting up to 72 hours.

Aust, M., Pototschnig, H., Jamchi, S., & Busch, K. H. (2018). Platelet-rich Plasma for Skin Rejuvenation and Treatment of Actinic Elastosis in the Lower Eyelid Area. Cureus, 10(7), e2999. doi:10.7759/cureus.2999

Loibl, M., Lang, S., Brockhoff, G., Gueorguiev, B., Hilber, F., Worlicek, M., Baumann, F., Grechenig, S., Zellner, J., Huber, M., Valderrabano, V., Angele, P., Nerlich, M., Prantl, L., & Gehmert, S. (2016). The effect of leukocyte-reduced platelet-rich plasma on the proliferation of autologous adipose-tissue derived mesenchymal stem cells. Clinical hemorheology and microcirculation, 61 4, 599-614